Diabetes Metab J.  2011 Oct;35(5):466-468. 10.4093/dmj.2011.35.5.466.

The Association between Carotid Atherosclerosis and Glucose

• Koo BK

• KMID: 1857501
• DOI: http://doi.org/10.4093/dmj.2011.35.5.466

Abstract

No abstract available.

MeSH Terms

Carotid Artery Diseases
Glucose
Glucose

Reference

1. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007. 115:459–467.

2. Paraskevas KI, Hamilton G, Mikhailidis DP. Statins: an essential component in the management of carotid artery disease. J Vasc Surg. 2007. 46:373–386.

3. Wang JG, Staessen JA, Li Y, Van Bortel LM, Nawrot T, Fagard R, Messerli FH, Safar M. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke. 2006. 37:1933–1940.

4. Katakami N, Kim YS, Kawamori R, Yamasaki Y. The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study--a randomized trial. Circulation. 2010. 121:2584–2591.

5. Ahn CW, Lee HC, Park SW, Song YD, Huh KB, Oh SJ, Kim YS, Choi YK, Kim JM, Lee TH. Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2001. 52:45–53.

6. Temelkova-Kurktschiev TS, Koehler C, Leonhardt W, Schaper F, Henkel E, Siegert G, Hanefeld M. Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors. Diabetes Care. 1999. 22:333–338.

7. O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK Jr, Bommer W, Price TR, Gardin JM, Savage PJ. The CHS Collaborative Research Group. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke. 1992. 23:1752–1760.

8. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991. 11:1245–1249.

9. Hacihamdioglu B, Okutan V, Yozgat Y, Yildirim D, Kocaoglu M, Lenk MK, Ozcan O. Abdominal obesity is an independent risk factor for increased carotid intima-media thickness in obese children. Turk J Pediatr. 2011. 53:48–54.

10. Litwin M, Niemirska A. Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol. 2009. 24:707–719.

11. Brohall G, Oden A, Fagerberg B. Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med. 2006. 23:609–616.

12. Bhuiyan AR, Srinivasan SR, Chen W, Paul TK, Berenson GS. Correlates of vascular structure and function measures in asymptomatic young adults: the Bogalusa Heart Study. Atherosclerosis. 2006. 189:1–7.

13. Temelkova-Kurktschiev T, Koehler C, Schaper F, Henkel E, Hahnefeld A, Fuecker K, Siegert G, Hanefeld M. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals. Diabetologia. 1998. 41:706–712.

14. Thalhammer C, Balzuweit B, Busjahn A, Walter C, Luft FC, Haller H. Endothelial cell dysfunction and arterial wall hypertrophy are associated with disturbed carbohydrate metabolism in patients at risk for cardiovascular disease. Arterioscler Thromb Vasc Biol. 1999. 19:1173–1179.

15. Hanefeld M. Treatment of impaired glucose tolerance with acarbose and its effect on intima-media thickness: a substudy of the STOP-NIDDM trial (study to prevent non-insulin-dependent diabetes mellitus). Endocr Pract. 2006. 12:Suppl 1. 56–59.

16. Giannini C, de Giorgis T, Scarinci A, Ciampani M, Marcovecchio ML, Chiarelli F, Mohn A. Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children. Atherosclerosis. 2008. 197:448–456.

17. Banerjee D, Recio-Mayoral A, Chitalia N, Kaski JC. Insulin resistance, inflammation, and vascular disease in nondiabetic predialysis chronic kidney disease patients. Clin Cardiol. 2011. 34:360–365.

18. Agewall S, Fagerberg B, Attvall S, Wendelhag I, Urbanavicius V, Wikstrand J. Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke. 1995. 26:956–960.

19. Mita T, Watada H, Uchino H, Shimizu T, Hirose T, Tanaka Y, Kawamori R. Association of C-reactive protein with early-stage carotid atherosclerosis in Japanese patients with early-state type 2 diabetes mellitus. Endocr J. 2006. 53:693–698.

20. Hee Choi S, Chang Kim H, Woo Ahn C, Keun Cho H, Soo Cha B, Chung YS, Woo Lee K, Chul Lee H, Bum Huh K, Kim DJ. Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Eur J Cardiovasc Prev Rehabil. 2005. 12:548–554.

21. Freitas WM, Quaglia LA, Santos SN, Soares AA, Japiassu AV, Boaventura V, dos Santos Barros E, Cordova C, Nobrega OT, Sposito AC. Association of systemic inflammatory activity with coronary and carotid atherosclerosis in the very elderly. Atherosclerosis. 2011. 216:212–216.

22. Metzger BE. Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol. 2007. 50:972–979.

23. Davis CL, Gutt M, Llabre MM, Marks JB, O'Sullivan MJ, Potter JE, Landel JL, Kumar M, Schneiderman N, Gellman M, Skyler JS. History of gestational diabetes, insulin resistance and coronary risk. J Diabetes Complications. 1999. 13:216–223.

24. Ku YH, Choi SH, Lim S, Cho YM, Park YJ, Park KS, Kim SY, Jang HC. Carotid intimal-medial thickness is not increased in women with previous gestational diabetes mellitus. Diabetes Metab J. 2011. 35:497–503.